News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,355 Results
Type
Article (87999)
Company Profile (825)
Press Release (781512)
Multimedia
Podcasts (196)
Webinars (28)
Section
Business (233276)
Career Advice (4147)
Deals (39884)
Drug Delivery (151)
Drug Development (91427)
Employer Resources (205)
FDA (18395)
Job Trends (17428)
News (397948)
Policy (39970)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (148)
Alliances (56982)
ALS (181)
Alzheimer's disease (1794)
Antibody-drug conjugate (ADC) (348)
Approvals (18576)
Artificial intelligence (628)
Autoimmune disease (163)
Automation (36)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (203)
Biotechnology (490)
Bladder cancer (163)
Brain cancer (65)
Breast cancer (667)
Cancer (5053)
Cardiovascular disease (445)
Career advice (3570)
Career pathing (41)
CAR-T (305)
CDC (59)
Celiac Disease (2)
Cell therapy (829)
Cervical cancer (37)
Clinical research (77046)
Collaboration (1824)
Company closure (5)
Compensation (1163)
Complete response letters (73)
COVID-19 (2993)
CRISPR (99)
C-suite (869)
Cystic fibrosis (154)
Data (6283)
Decentralized trials (2)
Denatured (72)
Depression (151)
Diabetes (535)
Diagnostics (7233)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (303)
Drug pricing (225)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100158)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135091)
Executive appointments (1033)
FDA (21586)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1558)
Gene editing (215)
Generative AI (65)
Gene therapy (673)
GLP-1 (1131)
Government (5442)
Grass and pollen (8)
Guidances (385)
Healthcare (20947)
HIV (61)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (292)
Immuno-oncology (59)
Indications (100)
Infectious disease (3280)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (249)
Interviews (816)
IPO (17955)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (69)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (99)
Longevity (16)
Lung cancer (680)
Lymphoma (379)
Machine learning (45)
Management (66)
Manufacturing (855)
MASH (174)
Medical device (15030)
Medtech (15083)
Mergers & acquisitions (22990)
Metabolic disorders (1402)
Multiple sclerosis (163)
NASH (23)
Neurodegenerative disease (356)
Neuropsychiatric disorders (99)
Neuroscience (3119)
Neurotech (1)
NextGen: Class of 2026 (7708)
Non-profit (5112)
Now hiring (66)
Obesity (678)
Opinion (336)
Ovarian cancer (167)
Pain (212)
Pancreatic cancer (231)
Parkinson's disease (301)
Partnered (39)
Patents (512)
Patient recruitment (484)
Peanut (60)
People (66921)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23805)
Phase 2 (33431)
Phase 3 (25196)
Pipeline (5107)
Policy (337)
Postmarket research (3554)
Preclinical (10694)
Press Release (72)
Prostate cancer (247)
Psychedelics (55)
Radiopharmaceuticals (301)
Rare diseases (909)
Real estate (7440)
Recruiting (80)
Regulatory (29041)
Reports (67)
Research institute (2725)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (257)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (177)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (101)
The Weekly (122)
Vaccines (1150)
Venture capital (96)
Weight loss (466)
Women's health (88)
Worklife (21)
Date
Today (94)
Last 7 days (549)
Last 30 days (2629)
Last 365 days (32844)
2026 (2666)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (90)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51569)
Australia (9058)
California (11563)
Canada (3320)
China (1172)
Colorado (490)
Connecticut (501)
Delaware (348)
Europe (118475)
Florida (1692)
Georgia (372)
Hawaii (4)
Idaho (68)
Illinois (966)
India (69)
Indiana (544)
Iowa (24)
Japan (430)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1459)
Massachusetts (8508)
Michigan (358)
Minnesota (666)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3113)
New Mexico (33)
New York (3054)
North Carolina (1612)
North Dakota (10)
Northern California (5531)
Ohio (354)
Oklahoma (22)
Oregon (55)
Pennsylvania (2313)
Puerto Rico (23)
Rhode Island (50)
South America (1662)
South Carolina (65)
South Dakota (1)
Southern California (4465)
Tennessee (177)
Texas (1826)
United States (41714)
Utah (346)
Vermont (1)
Virginia (290)
Washington D.C. (88)
Washington State (974)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
870,355 Results for "'".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NeuroDex Contributes to Landmark Review on Tissue-Specific Extracellular Vesicles and the Future of Liquid Biopsy
February 3, 2026
·
1 min read
Earnings
Pfizer’s Early Metsera Data Leaves Analysts Wanting More
Analysts parsed the limited data available for Pfizer’s obesity candidate on the pharma’s fourth-quarter earnings call Tuesday, looking for any nugget of additional context.
February 3, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
SiPhox Health Introduces a Smarter Way of Health Tracking From Home
February 3, 2026
·
1 min read
Press Releases
Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships
February 3, 2026
·
1 min read
Press Releases
French Supreme Court Decision Further Paves the Way to Market Access for CoorsTek Bioceramics’ Permallon(R) Orthopaedic Hip Components
February 3, 2026
·
1 min read
Earnings
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline
In its 2025 full year and fourth-quarter earnings call, Merck executives touted the merits of recent deals and what CEO Robert Davis called “probably the broadest and widest pipeline we’ve had in years.”
February 3, 2026
·
2 min read
·
Dan Samorodnitsky
Press Releases
BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT)
February 3, 2026
·
3 min read
Press Releases
Theriva™ Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026
February 3, 2026
·
8 min read
Press Releases
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - February 3, 2026
February 3, 2026
·
1 min read
Press Releases
Mesa Labs Announces Third Quarter Results - February 3, 2026
February 3, 2026
·
16 min read
1 of 87,036
Next
